This section is about issues of intellectual property in pharmaceutical industry.
Contributions from members are very welcome. Every article is published with full credentials of Author. Please Register as the member and submit your article.
|
|
Intellectual Propriatery News
|
|
Written by Zdravko Mauko
|
|
Monday, 02 January 2006 |
Strategies for early generic launch - Atorvastatin
 The major constraining patent for Atorvastaitn is EP-00247633. Patentee is Warner-Lambert company. Priority date is 30 May 1986. SPC for EP-00247633 will expire in Nov. 2011 in number of EU countries. However, in Slovenia, Czech R., Bulgaria, Hungary, Poland and Slovakia there is no national patents with link to EP-00247633 as primary patent.
|
|
Read more...
|
|
|
Intellectual Propriatery News
|
|
Written by Zdravko Mauko
|
|
Wednesday, 21 December 2005 |
Strategies for successful generic launch in European Union - Sildenafil caseThe experts of Framvita.Net have made an brief analysis of current status of intellectual property and generic products about sildenafil. This article may help you in planning of successful launch of generic sildenafil in European Union.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
| Results 19 - 20 of 20 |
Farmavita.Net Journal 
